91
Views
19
CrossRef citations to date
0
Altmetric
Original

Erythropoietin does not preserve motor neurons in a mouse model of familial ALS

, , , &
Pages 31-35 | Received 23 Jan 2006, Accepted 02 May 2006, Published online: 10 Jul 2009

References

  • Bendotti C., Carri M. T. Lessons from models of SOD1‐linked familial ALS. Trends Mol Med 2004; 10: 393–400
  • Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., et al. Deletion of the hypoxia‐response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001; 28: 131–8
  • Sakanaka M., Wen T. C., Matsuda S., Masuda S., Morishita E., Nagao M., et al. In vivo evidence that erythropoietin protects neurons from ischaemic damage. Proc Natl Acad Sci. USA 1998; 95: 4635–40
  • Brines M. L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N. C., Cerami C., et al. Erythropoietin crosses the blood‐brain barrier to protect against experimental brain injury. Proc Natl Acad Sci. USA 2000; 97: 10526–31
  • Siren A. L., Fratelli M., Brines M., Goemans C., Casagrande S., Lewczuk P., et al. Erythropoietin prevents neuronal apoptosis after cerebral ischaemia and metabolic stress. Proc Natl Acad Sci. USA 2001; 98: 4044–9
  • Celik M., Gokmen N., Erbayraktar S., Akhisaroglu M., Konakc S., Ulukus C., et al. Erythropoietin prevents motor neuron apoptosis and neurological disability in experimental spinal cord ischaemic injury. Proc Natl Acad Sci. USA 2002; 99: 2258–63
  • Agnello D., Bigini P., Villa P., Mennini T., Cerami A., Brines M. L., et al. Erythropoietin exerts an anti‐inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res 2002; 952: 128–34
  • Bianchi R., Buyukakilli B., Brines M., Savino C., Cavaletti G., Oggioni N., et al. Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci. USA 2004; 101: 823–8
  • Barber R. P., Phelps P. E., Houser C. R., Crawford G. D., Salvaterra P. M., Vaughn J. E. The morphology and distribution of neurons containing choline acetyltransferase in the adult rat spinal cord: an immunocytochemical study. J Comp Neurol 1984; 229: 329–46
  • Chung Y. H., Joo K. M., Kim Y. S., Lee K. H., Lee W. B., Cha C. I. Enhanced expression of erythropoietin in the central nervous system of SOD1(G93A) transgenic mice. Brain Res 2004; 1016: 272–80
  • Calvillo L., Latini R., Kajstura J., Leri A., Anversa P., Ghezzi P., et al. Recombinant human erythropoietin protects the myocardium from ischaemia‐reperfusion injury and promotes beneficial remodelling. Proc Natl Acad Sci. USA 2003; 100: 4802–6
  • Sathasivam S., Ince P. G., Shaw P. J. Apoptosis in amyotrophic lateral sclerosis: a review of the evidence. Neuropathol Appl Neurobiol 2001; 27: 257–74
  • Migheli A., Atzori C., Piva R., Tortarolo M., Girelli M., Schiffer D., et al. Lack of apoptosis in mice with ALS. Nat Med 1999; 5: 966–7
  • Guegan C., Przedborski S. Programmed cell death in amyotrophic lateral sclerosis. J Clin Invest 2003; 111: 153–61
  • Nguyen M. D., Boudreau M., Kriz J., Couillard‐Despres S., Kaplan D. R., Julien J. P. Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1. J Neurosci 2003; 23: 2131–40
  • Nagata Y., Moriguchi T., Nishida E., Todokoro K. Activation of p38 MAP kinase pathway by erythropoietin and interleukin‐3. Blood 1997; 90: 929–34
  • Tortarolo M., Veglianese P., Calvaresi N., Botturi A., Rossi C., Giorgini A., et al. Persistent activation of p38 mitogen‐activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol Cell Neurosci 2003; 23: 180–92
  • Ackerley S., Grierson A. J., Banner S., Perkinton M. S., Brownlees J., Byers H. L., et al. p38alpha stress‐activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Mol Cell Neurosci 2004; 26: 354–64
  • Gil J. M., Leist M., Popovic N., Brundin P., Petersen A. Asialoerythropoietin is not effective in the R6/2 line of Huntington's disease mice. BMC Neurosci 2004; 5: 17
  • Turmaine M., Raza A., Mahal A., Mangiarini L., Bates G. P., Davies S. W. Non‐apoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc Natl Acad Sci. USA 2000; 97: 8093–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.